Compounding that statistic, prior studies indicate some trans people at high risk for HIV transmission are hesitant to take ...

According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million ...

PrEP has transformed HIV prevention in the United States. When taken as prescribed, PrEP significantly reduces the risk of ...

A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the ...

For several years, pre-exposure prophylaxis against HIV (PrEP) has been a major success in preventing new cases. However, ...

The memo circulated by the State Department’s Global Health Security and Diplomacy program states, “People other than PBFW ...

AIDS Healthcare Foundation (AHF) has launched two new national billboard and outdoor advertising campaigns. The first, "50 Countries -- 2.7 Million in Care," celebrates a historic AHF milestone: ...

World AIDS Day is marked every year on 1 December. It began in 1988 and is recognised worldwide by the World Health ...

In honour of World AIDS Day, Impulse Cape Town took to the streets of Langa to educate residents about HIV and queer health rights.

We finally have the technology, infrastructure, and the political will to end the US HIV epidemic, write the Brown University doctors who lead the Rhode Island Public Health Institute. But access to ...

The National Institute for Health and Care Excellence (NICE) has recommended cabotegravir (Apretude, ViiV Healthcare), an injectable form of preexposure prophylaxis (PrEP), marking a major milestone ...

ViiV Healthcare, a healthcare company founded by Pfizer (NYSE:PFE) and GSK (NYSE:GSK), announced on Wednesday that its long-acting HIV PrEP therapy cabotegravir was found to be more acceptable to ...